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B
ioactive natural product phosphonates and phosphinates are
widely employed in medicine and agriculture.
1 One example
of this class of molecules is phosphinothricin (PT), which is
the active ingredient in a number of commercially important
herbicides.
2,3 Recent investigations into the PT biosynthetic
pathway revealed a number of previously uncharacterized trans-
formations, including an unusual carbon carbon bond cleavage
during the conversion of 2-hydroxyethylphosphonate (2-HEP)
tohydroxymethylphosphonate(HMP)andformatecatalyzedby
2-hydroxyethylphosphonate dioxygenase (HEPD) (Scheme 1).
4,5
HMP is then further elaborated to provide PT tripeptide in 15
enzymatic transformations.
4
Biochemical and structural characterization of HEPD has
shown that it is a mononuclear non-heme Fe(II)-dependent
dioxygenasethat does notrequirean externalsourceof electrons
such as R-ketoglutarate. The use of labeled substrates (2-HEP
isotopologues,
18O2, and H2
18O) showed that one of the atoms
of dioxygen ends up in formate.
5 The second oxygen atom is
incorporated into the hydroxyl group of HMP in a substoichio-
metric fashion, as some of the oxygen exchanges with solvent.
5
Surprisingly, experiments with 2-HEP that was stereospeciﬁcally
labeled with deuterium at C1 demonstrated that the HMP
produced was racemic (Scheme 1).
6 Several mechanisms that
can explain the results of these labeling studies have been proposed
recently,
6,7 but these mechanisms do not explain why HEPD
c o n v e r t st h es u b s t r a t ea n a l o g u e1 -HEP to acetylphosphate, which
could betheresultofaCriegeerearrangement(Scheme1).
8In this
study, we examined several alternative mechanisms that could
account for all experimental observations thus far. Additionally,
we introduced mutations at residues responsible for binding
2-HEP in the active site of HEPD in the hopes that these active
sitemutantsmightperturbthechemistryofHEPDandprovidea
glimpse into the catalytic cycle.
’MATERIALS AND METHODS
Materials. 2-Nitrophenylhydrazine was obtained from Acros
Organics. N-[3-(Dimethylamino)propyl]-N0-ethylcarbodiimide
was purchased from Chem-Impex. NAP-5 and NAP-25 columns
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carboxylate non-heme iron-dependent dioxygenases. It con-
verts 2-hydroxyethylphosphonate (2-HEP) to hydroxymethyl-
phosphonate (HMP) and formate. Previously postulated
mechanismsforthereactioncatalyzedbyHEPDcannotexplain
its conversion of 1-HEP to acetylphosphate. Alternative me-
chanisms that involve either phosphite or methylphosphonate
as intermediates, which potentially explain all experimental
studies including isotope labeling experiments and useof substrate
analogues, were investigated. The results of these studies reveal
that these alternative mechanisms are not correct. Site-directed
mutagenesisstudiesofLys16,Arg90,andTyr98supportrolesof
these residues in binding of 2-HEP. Mutation of Lys16 to Ala resulted in an inactive enzyme, whereas mutation of Arg90 to Ala or
Tyr98 to Phe greatly decreased kcat/Km,2-HEP. Furthermore, the latter mutants could not be saturated in O2. These results suggest
that proper binding of 2-HEP is important for O2 activation and that the enzyme uses a compulsory binding order with 2-HEP
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were purchased from GE Healthcare. All other materials were
purchased from Sigma Aldrich unless otherwise noted.
Mutagenesis.Site-directed mutagenesis was performedusing
theQuikChangemutagenesiskit(Stratagene).Primersequences
are available in the Supporting Information.
Protein Preparation. HEPD was expressed and purified as
previously described.
5 For kinetic assays, HEPD was further
purified by size exclusion chromatography (Superdex 200 pre-
parative grade resin, GE Healthcare). In a typical reconstitution,
HEPD (70 200 μM for O2 kinetics, up to 1 mM for
31P NMR
assays) was anaerobically incubated with Fe(II) [1 equiv of
(NH4)2Fe(SO4)236H2O] on ice for at least 10 min in 25 mM
HEPES (pH 7.5). All assays were performed in air-saturated
25 mM HEPES (pH 7.5) at 20 C unless otherwise described.
Kinetic Assays. A Hansatech O2 electrode was used to generate
Michaelis Menten curves by varying one substrate concentration
while keeping the second substrate at saturating concentrations
(when possible) and at a constant HEPD concentration (2 μMf o r
the wild type, 5 μM for R90K and Y98F, and 10 μM for R90A;
25 μM K16A was used to ensure no activity was observed for this
inactive mutant at higher enzyme concentrations). All reactions
were initiated by addition of 2-HEP. The initial rate of O2 consump-
tion was measured in triplicate and normalized for the enzyme
concentration.NonlinearregressionswerecalculatedusingIgorPro
version 6.1.
Liquid Chromatography Mass Spectrometry (LC MS)
Assays. Formate production assays were conducted as pre-
viouslydescribed.
8LC MSanalysisofphosphonatecompounds
was conducted using a hydrophilic interaction chromatography
column (SeQuant ZIC-HILIC, 2.1 mm   150 mm) followed by
direct infusion onto a linear ion-trap/Fourier-transform hybrid
mass spectrometer.
NMR Spectroscopy Assays.
31P NMR spectra were recorded
on a Varian Unity Inova 600 spectrometer tuned to 242.79 MHz
and referenced to an external standard (85% H3PO4, δ = 0). For
analysis of enzymatic products by NMR spectroscopy, reconsti-
tuted protein (100 μM) was added to 2-HEP (0.5 2 mM) in
oxygenated buffer. After incubation for 1 2 h, EDTA (50 mM),
dithionite(20mM),andD2O[finalconcentrationof20%(v/v)]
were added, and the spectrum was recorded. Because of the
sensitivity of chemical shifts recorded by
31P NMR spectroscopy
tosmallchangesinpH,theidentityofallproductswasconfirmed
by spiking with authentic synthetic compounds. Spectra were
plotted with MestReNova-Lite.
Size Exclusion Chromatography. All size exclusion chroma-
tographic experiments were conducted with an isocratic gel
filtration buffer [200 mM KCl, 50 mM HEPES (pH 7.5), and
10% glycerol]. Analytical size exclusion chromatography was
conducted at 20 C with a flow rate of 1.0 mL/min on an HPLC
Gel Filtration BioSil-250 column. Analytes were typically run at
concentrations of 20 100 μMw i t h2 0μL injections. Standards
were bovine serum albumin, yeast alcohol dehydrogenase,
β-amylase, carbonic anhydrase from bovine erythrocytes, and
cytochrome c oxidase from horse heart. Blue dextran was used to
determinethevoidvolume.Theelutionvolume(Ve)wasdivided
bythevoidvolume(V0),andtheparameterVe/V0wascorrelated
to the log of the molecular weight of the protein to construct a
calibration curve.
DeterminationoftheCrystalStructureofY98F.Acrystalof
the HEPD-Y98F mutant, from which the His6 tag had been
removed with thrombin, was obtained as previously reported for
wild-typeHEPD.
5A6-foldredundantdatasetwascollectedfrom
a crystal of HEPD-Y98F on a Mar 300 CCD detector (LSCAT,
Sector 21 ID-D, Advanced Photon Source, Argonne, IL). Data
were indexed and scaled using the HKL2000 package
9 as summar-
ized in Table S1 of the Supporting Information. The structure was
determined via molecular replacement with apo-HEPD [Protein
Data Bank (PDB) entry 3G7D] as the search model using
MOLREP
10 in the CCP4 suite.
11 Model building and refining
were performed with COOT.
12 Refinement cycles and genera-
tion of electron density maps were accomplished with the CNS
suite of programs
13 until the R values no longer improved. PyMOL
(DeLano Scientific, San Carlos, CA) was used to generate
graphic images. The root-mean-square deviation between the
mutant and wild-type HEPD was calculated via structural compar-
ison using TopMatch.
14,15
’RESULTS
Racemization of HMP Does Not Occur after Its Initial
Formation.Previouslyproposedmechanismsfortheconversion
of 2-HEP to HMP and formate do not provide a satisfactory
explanation for racemization both at C1 in the conversion of
2-HEPtoHMP
6andtheproductionofacetylphosphatefromthe
substrate analogue 1-HEP
8 (Scheme 1). On the basis of pre-
cedent in organic chemistry,
14 the latter product suggests the
involvement of a Criegee rearrangement from a hydroperoxyla-
tion product, but such rearrangements result in retention of
stereochemistry. One model that would be consistent with the
outcome of both previous studies is shown in Scheme 2.
In thismechanism, ahydroperoxylation process isfollowed by
a Criegee rearrangement (step 4) and hydrolysis to form HMP
Scheme 1. HEPD Requires Only Ferrous Iron and O2 To Convert 2-HEP to HMP
a
aThe enzyme abstracts the pro-S hydrogen from C2, and all stereochemical information about C1 is lost in the product HMP. HEPD also converts
(S)-1-HEP to acetylphosphate, possibly via a Criegee intermediate as shown.6600 dx.doi.org/10.1021/bi200804r |Biochemistry 2011, 50, 6598–6605
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(step 5), as previously proposed.
8 After formation of HMP, the
P C bond in the product could be transiently broken, generat-
ing phosphite and formaldehyde in the active site of HEPD
(step 6). If the formaldehyde is able to rotate along the CdO
bond, then phosphite could attack either face of the carbonyl
group resulting in a loss of stereochemistry. In an eﬀort to test
this possibility, (R)-[
2H1]HMP
6,15 was incubated with HEPD
under anaerobic conditions. Subsequently, the solution was
sparged with oxygen to eﬀect the slow but stereospeciﬁc con-
version of HMP to phosphate and formate.
6 If the (R)-[
2H1]-
HMP had (partially) racemized, then deuterium would be
incorporated into formate to the same extent that racemization
occurred. However, analysis of the formate by LC MS after
derivatization
8 did not show any deuterium incorporation, and
hence, the experiment provided no evidence of racemization of
(R)-[
2H1]HMP.
Investigation of a Potential Methylphosphonate Inter-
mediate. Another possible mechanism that could account for
theproductionofracemicHMPfrom(R)-or(S)-2-[1-
2H1]HEP
as well as the generation of acetylphosphate from 1-HEP is
shown in Scheme 3. In this model, hydroperoxylation product I,
generatedasinScheme2,wouldundergoC Cbondcleavageto
produce performic acid and methylphosphonate (MPn), an
intermediate from which all stereochemical information would
be lost. On the basis of literature precedent with model com-
pounds,
16 the performic acid could oxidize the iron to the
corresponding ferryl species II, which could abstract a hydrogen
atomfromMPn.Reboundoftheferrichydroxideandtheorganic
radical would generate the HMP product and reset the enzyme
for another turnover. This mechanism could also explain the
formation of acetylphosphate from 1-HEP if the hydroperoxy-
latedintermediateIageneratedwiththissubstrateanaloguewere
to undergo a Criegee rearrangement instead of formation of
peracetic acid (inset of Scheme 3).
Prima facie, the mechanism in Scheme 3 appears to be
inconsistent with the previously observed retention of both
deuterium atoms in HMP after oxidation of 2-[1-
2H2]HEP by
HEPD.
5 The mechanism in Scheme 3 would predict incorpora-
tion of a proton from solvent in methylphosphonate, and at least
partial retention of this proton in the ﬁnal product. However,
hydrogen atom abstractions by ferryl species have been reported
to result in large deuterium kinetic isotope eﬀects (KIEs) of
50 60 in TauD
17 and prolyl-4-hydroxylase.
18 A similarly strong
discrimination against the abstraction of deuterium from [CHD2]-
MPn by ferryl intermediate II in HEPD would account for
retention of both deuterium atoms in HMP because the sensi-
tivity of the assay used would not be suﬃcient to detect <5%
monodeuterated HMP. If the mechanism in Scheme 3 is opera-
tional with a large KIE, then an experiment performed with
unlabeled2-HEPinD2OshouldproducemonodeuteratedHMP
(Scheme 4).
Therefore, HEPD was incubated with 2-HEP in buﬀer pre-
pared in D2O (>99.8% D-labeled), and the HMP generated was
Scheme 2. Reversible Formation of Phosphite and Formaldehyde from HMP in the Active Site of HEPD Could Account for the
Observed Racemization at C1
Scheme 3. Formation of an Achiral Methylphosphonate
Intermediate Could Explain the Racemization of HMP
a
aAlternative breakdown of peroxyacetal Ia formed with 1-HEP would
also explain the formation of acetylphosphate with this substrate analogue.6601 dx.doi.org/10.1021/bi200804r |Biochemistry 2011, 50, 6598–6605
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analyzed by liquid chromatography Fourier transform mass
spectrometry (LC FTMS). Extracted ion chromatograms were
obtained using a linear ion-trap Fourier transform hybrid mass
spectrometer allowing a 10 ppm mass error with respect to the
theoretical masses. This method can distinguish between [
2H1]-
HMP and other analytes such as natural abundance [
13C]HMP.
No [
2H1]HMP was detected (Figure 1), indicating that the mechan-
ism in Scheme 4 cannot be correct. Although not discussed here
in detail, this result also rules out a hydroxylation mechanism
with a methylphosphonate intermediate (see Scheme S1 of the
Supporting Information).
Mutagenesis of Substrate Binding Residues. Inspection of
the cocrystal structure of 2-HEP bound to HEPD in which
Cd(II) occupied the iron binding site led to the identification of
several residues that appear to be involved in substrate binding
(Figure 2). Several mutants of these residues were generated to
investigate the importance of these residues for catalysiswith the
motivation that it might be possible to perturb the chemistry
performed by HEPD and thereby glean insight into the mechan-
ism. To allow comparison of their kinetic parameters with those
of the wild-type (wt) enzyme, a continuous steady state kinetics
assaywasdevelopedusinganoxygenelectrode.Wild-typeHEPD
demonstrated a typical hyperbolic dependence on the concen-
trations of both 2-HEP and O2 (Figure 3 and Figure S1 of the
Supporting Information). Michaelis Menten curves with the
concentration of one substrate being varied and that of the
second substrate being held at a saturating level allowed deter-
minationoftheKmvaluesforbothsubstratesaswellaskcatforwt
HEPD (Figure 3 and Table 1). In the X-ray structure, Arg90
interacts with the phosphonate moiety of 2-HEP through an
intermediate water molecule (Figure 2). Site-directed mutagen-
esis afforded the R90A mutant, which was shown by
31P NMR
spectroscopy and LC MS to convert 2-HEP to HMP and
formate (Figures S2 and S3 of the Supporting Information).
Analysisofthekineticsofthereactionusingtheoxygenelectrode
assayshowedthatthemutationresultedinamuchhigherapparentKm
for2-HEPcomparedtothatofwtHEPD(Figure3).Becausethe
R90A mutant could not be saturated in O2 (Figure S1 of the
Supporting Information), individual values for Km,O2 and kcat
could not be determined. From the observed rates at various
oxygen concentrations, a value of 100 ( 1M
 1 s
 1 could be
estimated forkcat/Km,O2.TheR90Kmutant wasalsoconstructed
and shown to convert 2-HEP to HMP and formate by
31P NMR
spectroscopy and LC MS (Figures S2and S3 ofthe Supporting
Information), respectively. Its Km for 2-HEP was increased
comparedtothatofwtHEPDbutnotassignificantlyasobserved
for R90A (Table 1). Under O2 saturating conditions, the
calculated kcat of the R90K mutant is comparable to that of wt,
demonstrating that the mutation of Arg to Lys provided full
HEPD activity at higher 2-HEP concentrations.
A tyrosine-lysine pair crucial for substrate binding has been
observed in several enzymes involved in phosphonate biosynth-
esis,includingHppEinvolvedinfosfomycinbiosynthesisandthe
O-methyltransferase DhpI involved in the biosynthesis of
dehydrophos.
20 22 In HEPD, Lys16 and Tyr98 constitute this
Scheme 4. Conversion of 2-HEP to Formate and HMP in
D2OWouldResultin[
2H1]HMPIfMethylphosphonateWere
an Intermediate
Figure 1. Extracted ion chromatograms (EIC) of reaction mixtures of
2-HEP incubated with wild-type HEPD in D2O. [
1H2]HMP was
observed (red, calculated m/z 110.9847, found m/z 110.9852), but
[
2H1]HMP (blue) was not detected.
Figure 2. View of the active site of Cd(II)-substituted HEPD with
2-HEP bound. The 2-His-1-carboxylate triad binds Cd(II), to which
2-HEPcoordinatesinabidentatefashion.Lys16,Arg90,andTyr98form
part of a hydrogen bonding network that anchors 2-HEP in the active site.6602 dx.doi.org/10.1021/bi200804r |Biochemistry 2011, 50, 6598–6605
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pair of residues (Figure 2). In the cocrystal structure of HEPD
with 2-HEP, Lys16 protrudes from one monomer into the active
site of the other monomer to interact with the phosphonate
moiety of 2-HEP. To probe the importance of this residue, the
K16A mutant was constructed. Consistent with the ﬁndings for
similar mutants of DhpI
19 and HppE,
21 the lysine to alanine
substitution completely abolished activity. To examine whether
this inactivation was a consequence of the abolition of a vital
electrostatic interaction with the substrate or disruption of the
dimer interface, analytical gel ﬁltration was performed on the
mutant and wt enzyme. Both the wt apoenzyme and the enzyme
reconstituted with Fe(II) eluted as dimers, and the elution
proﬁlesofK16Acould besuperimposed withthoseofwtHEPD,
indicatingthatLys16likelyformsanelectrostaticinteractionthat
is critical for binding 2-HEP in the active site of HEPD.
In the Cd(II) HEPD crystal structure without substrate, the
phenolicoxygenofTyr98pointsawayfromtheactivesite.When
2-HEP was cocrystallized with HEPD, Tyr98 was observed to
undergo a substantial torsional rotation to move the phenolic
oxygentowardthephosphonatemoietyof2-HEP.Toinvestigate
the importance of Tyr98 for catalysis, we generated the Y98F
mutant. The mutant still converted 2-HEP to HMP and formate
as observed by
31P NMR spectroscopy and LC MS (Figures S2
and S3 of the Supporting Information), but in contrast to that of
wtHEPD,whichconsumedO2withoutalossofcatalyticactivity,
t h er a t eo fc o n s u m p t i o no fO 2 by HEPD-Y98F gradually
decreased until the enzyme had lost all activity well before
substrate had been consumed (Figure S4 of the Supporting
Information); addition of more substrate or reductant did not
result in reactivation of the mutant. Inactivation was suﬃciently
slow that kinetic parameters could be determined (Figure 3 and
Table 1). Characterization of the Michaelis Menten kinetics
using the oxygen electrode assay demonstrated a large increase
in the apparent Km,2-HEP, and like that of R90A, the rate of
catalysisbyY98FcouldnotbesaturatedinO2(FigureS1ofthe
Supporting Information).
To further investigate the slow inactivation of Y98F, we
analyzed the products via LC FTMS, a technique that is more
sensitive than
31P NMR spectroscopy. Low levels of MPn
(Figure S5 of the Supporting Information) were detected, which
wasnotobservedwithwtHEPDortheothermutants.LikeMPn
detectedintheassay,MPnauthenticstandards wereconsistently
detected as dimers (theoretical mass of m/z 190.9874, found
massofm/z190.9877).Todeterminetheoriginoftheadditional
hydrogenonthemethylgroupofMPn,Y98Fwasincubatedwith
2-HEP in D2O. No incorporation of deuterium into MPn was
observed (Figure 4), suggesting the intermediacy of an MPn
radical rather than an MPn anion.
To investigate whether the mutation had caused any substan-
tial changes to the active site, the crystal structure of the Y98F
mutant was determined (Figure 5). Comparison with the
structure ofwt HEPDshows thattheloss of thephenolicoxygen
does not substantially perturb the overall structure [root-mean-
square deviation of CR atoms of 0.3 Å compared to Cd(II)-bound
Figure 3. Kinetics of oxidation of 2-HEP by HEPD: (A) wt, (B) R90A, (C) R90K, and (D) Y98F. All data were obtained with air-saturated buﬀer.
Table 1. Kinetic Parameters of HEPD and Its Variants
HEPD kcat (s
 1) Km,2-HEP (μM) kcat/Km,2-HEP (M
 1 s
 1) Km,O2 (μM) kcat/Km,O2 (M
 1 s
 1)
wild type 0.35 ( 0.01 9.8 ( 1 (3.6 ( 0.3)   10
4 33 ( 1 (11 ( 0.02)   10
3
R90A N/A
b 690 ( 140
a N/A
b N/A
b 100 ( 1
R90K 0.81 ( 0.01
c 60 ( 6 (1.3 ( 0.1)   10
4 100 ( 1 (8.1 ( 0.04)   10
3
K16A inactive inactive inactive inactive inactive
Y98F N/A
b 800 ( 110
a N/A
b N/A
b 740 ( 30
aApparent Km value.
bCould not be obtained as these mutants could not be saturated in O2 (see the text).
cSee Figure S1C.6603 dx.doi.org/10.1021/bi200804r |Biochemistry 2011, 50, 6598–6605
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HEPD].Furthermore,thearrangementoftheactivesiteofY98F
is very similar to that of the wild type. The phenylalanine residue
points away from the active site as in the apo-HEPD structure,
and without the phenolic oxygen, it is unlikely that the pheny-
lalaninewouldrotatetowardtheactivesiteupon2-HEPbinding.
Attempts to determine a cocrystal structure were unsuccessful,
underscoringagaintheimportanceoftheY98residueforbinding
of 2-HEP.
’DISCUSSION
The recent ﬁnding that the stereochemical information about
C1 of 2-HEP is lost during its conversion to HMP by HEPD
required revision of the originally proposed mechanisms.
5 Sev-
eral new mechanistic scenarios were suggested,
6 8 but none
couldprovidearationaleforhowthesubstrateanalogue1-HEPis
converted to acetylphosphate by HEPD. In this work, we
evaluated two new mechanisms that, if operative, could explain
both the loss of stereochemistry and the apparent involvement
of a Criegee rearrangement, and hence the intermediacy of a
hydroperoxylationproduct.However,experimentaltestsofthese
new mechanisms argue against both scenarios. We therefore are
left with the conclusion that the substrate analogue 1-HEP
induces alternative chemistry, which is not unusual for non-
heme iron-dependent enzymes (e.g., refs 20 22)
For the reaction with the native substrate 2-HEP, two mechan-
isms can account for all experimental observations (Scheme 5).
The results with the R90A and Y98F mutants provide experi-
mental support that 2-HEP binds prior to dioxygen because the
enzyme could be saturated in 2-HEP but not O2. The latter
observation suggests that the Arg90 and Tyr98 residues are
important not only for binding of 2-HEP but also for orienting
the substrate such that it activates the Fe(II) ion for O2 binding.
Bidentate binding of substrate has been suggested previously to
facilitate oxygen activation.
5,21,22 The results reported here for
Arg90, Lys16, and Tyr98 mutants also illustrate the importance
of these residues for phosphonate binding as the apparent Km,2-
HEP values increased greatly for the R90A and Y98F mutants
whereas the K16A mutant was entirely inactive.
After oxygen binding, the resulting ferric superoxo species is
postulated to abstract the pro-S hydrogen atom from C2 of
2-HEPtogenerateasubstrateradicalasshowninScheme5.The
intermediate radical is then hydroxylated (pathway A) or under-
goes a one-electron transfer to the iron to generate an aldehyde
IV (pathway B).
Figure 4. EICs of reaction mixtures of HEPD-Y98F with 2-HEP in D2O.
Only protiated MPn (red, found mass of m/z 190.9877, calculated mass of
m/z 190.9874 for the [MPn]2
  dimer) was observed, and deuterium-
labeled MPn (blue) was not detected (within a 10 ppm mass error).
Scheme 5. Two Mechanisms That Can Account for the Observed Experimental Outcomes during 2-HEP Oxidation
Figure 5. Overlay of apo-HEPD, HEPD with 2-HEP bound, and
HEPD-Y98F. Iron-binding residues, Cd(II), and Phe98 are colored
green and are from the mutant structure (PDB entry 3RZZ). Colored
gray are 2-HEP and Tyr98 from the liganded wt HEPD structure (PDB
entry 3GBF). Colored blue is Tyr98 from apo-HEPD (PDB entry
3G7D). Tyr98 undergoes a torsional rotation into the active site as a
result of a hydrogen bond that forms between the phenolic oxygen of
tyrosine and a phosphonate oxygen of 2-HEP.6604 dx.doi.org/10.1021/bi200804r |Biochemistry 2011, 50, 6598–6605
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In pathway A, C C bond cleavage generates an anion that
is oxidized to radical III, at which point the stereochemistry
may be lost. Rebound with the ferric hydroxide then provides
HMP. Exchange of either the ferryl or ferric hydroxide inter-
mediates with solvent can account for the observed incorpora-
tion of oxygen derived from solvent into HMP.
5 In pathway B,
favored by DFT calculations,
7 a bridged peroxo intermediate
V is formed in which the O O bond is cleaved homolytically
togenerateaferrichydroxideandradicalVI,whichundergoes
β-scission to generate the same methylphosphonate radical
III as in pathway A. This radical can then combine with the
ferric hydroxide to generateH M Pa n dr e s e tt h ee n z y m ef o r
another turnover. Once more, solvent exchange of the ferric
hydroxide can account for incorporation of oxygen from solvent
into HMP.
The observation that during inactivation of Y98F the hydro-
gen in MPn is not derived from solvent provides additional
indirect support for the mechanisms shown in Scheme 5. Given
the short distance (2.32 Å) between the phenolic oxygen of Tyr98
and one of the oxygens of the phosphonate group of 2-HEP in
theX-raystructureofwtHEPD,thelossofthishydrogenbondin
the Y98F mutant may result in a less well-deﬁned binding con-
formationofthesubstrateduringcatalysis.Inturn,thismayresult
insuboptimalarrangementofradicalIIIwithrespecttotheferric
hydroxide for rebound, resulting in abstraction of a hydrogen
atom from the protein that initiates irreversible inactivation.
In summary, these data rule out the presence of phosphite or
methylphosphonate intermediates that would account for the
observed loss ofstereochemicalinformation about C1of 2-HEP.
OnthebasisofthecrystalstructureofHEPD,threeresiduesthat
are crucial for anchoring the phosphonate moiety of 2-HEP
during catalysis were identiﬁed, and their importance was con-
ﬁrmed via characterization of the oxidation kinetics of various
site-directedmutants.Thesemutationalstudieshaveledustothe
conclusion that the mechanism of HEPD involves a compulsory
binding order with substrate binding triggering O2 binding and
subsequent activation for catalysis. Moreover, analysis of the
chemistry of the Y98F mutant indicates that the last step is likely
ferric hydroxide rebound with an MPn radical.
’ASSOCIATED CONTENT
b S Supporting Information. Primers used for site-directed
mutagenesis, an alternative mechanism that invokes the inter-
mediacy of methylphosphonate, plots showing the dependence
of rates on O2 concentration, NMR and MS analysis of the
products of HEPD mutants, and reﬁnement statistics for the
HEPD-Y98F crystal structure. This material is available free of
charge via the Internet at http://pubs.acs.org.
’AUTHOR INFORMATION
Corresponding Author
*Telephone:(217) 244-5360.Fax:(217) 244-8533.E-mail:vddonk@
illinois.edu.
Funding Sources
This work was supported by the National Institutes of Health
(GM077596 to W.A.v.d.D.). S.C.P. is atraineeinthe Chemistry-
Biology Interface Training Program (T32 GM070421). H.A.C.
holdsaNationalInstitutesofHealthNRSAPostdoctoralFellow-
ship (F32 GM95024-01).
’ACKNOWLEDGMENT
We thank Drs. Bradley Evans and Changming Zhao for help
with LC FTMS analysis.
’ABBREVIATIONS
PT, phosphinothricin;2-HEP, 2-hydroxyethylphosphonate;HMP,
hydroxymethylphosphonate;HEPD, 2-hydroxyethylphosphonate
dioxygenase;MPn,methylphosphonate;EIC,extractedionchroma-
togram;wt, wild-type;HppE, hydroxypropylphosphonate epoxidase.
’REFERENCES
(1) Metcalf, W. W., and van der Donk, W. A. (2009) Biosynthesis of
Phosphonic and Phosphinic Acid Natural Products. Annu. Rev. Biochem.
78,6 5 –94.
(2) Bayer, E.,Gugel, K.H., H€ agele, K.,Hagenmaier, H., Jessipow, S.,
K€ o n i g ,W .A . ,a n dZ € ahner, H. (1972) Stofwechselprodukte von
Mikroorganismen 98. Mitteilung. Phosphinothricin und phosphinothricyl-
alanyl-alanin. Helv. Chim. Acta 55,2 2 4 –239.
(3) Thompson, C. J., and Seto, H. (1995) Bialaphos. Biotechnology
28, 197–222.
(4) Blodgett, J. A., Thomas, P. M., Li, G., Velasquez, J. E., van der
Donk, W. A., Kelleher, N. L., and Metcalf, W. W. (2007) Unusual
transformations in the biosynthesis of the antibiotic phosphinothricin
tripeptide. Nat. Chem. Biol. 3, 480–485.
(5) Cicchillo, R. M., Zhang, H., Blodgett, J. A. V., Whitteck, J. T., Li,
G., Nair, S. K., van der Donk, W. A., and Metcalf, W. W. (2009) An
unusual carbon-carbon bond cleavage reaction during phosphinothricin
biosynthesis. Nature 459, 871–874.
(6) Whitteck, J. T., Malova, P., Peck, S. C., Cicchillo, R. M.,
Hammerschmidt, F., and van der Donk, W. A. (2011) On the stereo-
chemistry of2-hydroxyethylphosphonate dioxygenase.J.Am.Chem.Soc.
133, 4236–4239.
(7) Hirao, H., and Morokuma, K. (2010) Ferric Superoxide and
Ferric Hydroxide Are Used in the Catalytic Mechanism of Hydro-
xyethylphosphonate Dioxygenase: A Density Functional Theory Inves-
tigation. J. Am. Chem. Soc. 132, 17901–17909.
(8) Whitteck,J.T.,Cicchillo,R.M.,andvanderDonk,W.A.(2009)
Hydroperoxylation by hydroxyethylphosphonate dioxygenase. J. Am.
Chem. Soc. 131, 16225–16232.
(9) Otwinowski, Z., and Minor, W. (1997) Processing of X-ray
diﬀraction data collected in oscillation mode. Methods Enzymol. 276,
307–326.
(10) Vagin, A., and Teplyakov, A. (1997) MOLREP: An automated
program for molecular replacement. J. Appl. Crystallogr. 30, 1022–1025.
(11) Bailey, S. (1994) The CCP4 Suite: Programs for Protein
Crystallography. Acta Crystallogr. D50, 760–763.
(12) Emsley, P., and Cowtan, K.(2004) Coot: Model-building tools
for molecular graphics. Acta Crystallogr. D60, 2126–2132.
(13) Brunger, A. T. (2007) Version 1.2 of the Crystallography and
NMR system. Nat. Protoc. 2, 2728–2733.
(14) Gordon,N.J.,andEvans,S.A.,Jr.(1993)Acylphosphatesfrom
acylphosphonates:AnovelBaeyer-Villigerrearrangement.J.Org.Chem.
58, 4516–4519.
(15) Kapeller, D., Barth, R., Mereiter, K., and Hammerschmidt, F.
(2007) Preparation of chiral R-oxy-[
2H1]methyllithiums of 99% ee and
determination of their conﬁgurational stability. J. Am. Chem. Soc.
129, 914–923.
(16) Lim, M. H., Rohde, J.-U., Stubna, A., Bukowski, M. R., Costas,
M., Ho, R. Y. N., M€ unck, E., Nam, W., and Que, L., Jr. (2003) An
Fe(IV)O complex of a tetradentate tripodal nonheme ligand. Proc. Natl.
Acad. Sci. U.S.A. 100, 3665–3670.
(17) Price, J. C., Barr, E. W., Glass, T. E., Krebs, C., and Bollinger,
J.M.,Jr.(2003)EvidenceforhydrogenabstractionfromC1oftaurineby
the high-spin Fe(IV) intermediate detected during oxygen activation by6605 dx.doi.org/10.1021/bi200804r |Biochemistry 2011, 50, 6598–6605
Biochemistry ARTICLE
taurine:R-ketoglutarate dioxygenase (TauD). J. Am. Chem. Soc. 125,
13008–13009.
(18) Hoﬀart,L.M.,Barr,E.W.,Guyer,R.B.,Bollinger,J.M.,Jr.,and
Krebs,C.(2006)DirectspectroscopicdetectionofaC-H-cleavinghigh-
spin Fe(IV) complex in a prolyl-4-hydroxylase. Proc. Natl. Acad. Sci. U.S.
A. 103, 14738–14743.
(19) Lee, J. H., Bae, B., Kuemin, M., Circello, B. T., Metcalf, W. W.,
Nair, S. K., and van der Donk, W. A. (2010) Characterization and
structure of DhpI, a phosphonate O-methyltransferase involved in
dehydrophos biosynthesis. P r o c .N a t l .A c a d .S c i .U . S . A .1 0 7 , 17557–17562.
(20) Ogle, J. M., Clifton, I. J., Rutledge, P. J., Elkins, J. M., Burzlaﬀ,
N.I.,Adlington,R.M.,Roach,P.L.,andBaldwin,J.E.(2001)Alternative
oxidation by isopenicillin N synthase observed by X-ray diﬀraction.
Chem. Biol. 8, 1231–1237.
(21) Zhao, Z., Liu, P., Murakami, K., Kuzuyama, T., Seto, H., and
Liu, H. W. (2002) Mechanistic Studies of HPP Epoxidase: Conﬁgura-
tion of the Substrate Governs Its Enzymatic Fate. Angew. Chem., Int. Ed.
41, 4529–4532.
(22) Yan, F., Moon, S. J., Liu, P., Zhao, Z., Lipscomb, J. D., Liu, A.,
and Liu, H. W. (2007) Determination of the substrate binding mode to
the active site iron of (S)-2-hydroxypropylphosphonic acid epoxidase
using
17O-enriched substrates and substrate analogues. Biochemistry
46, 12628–12638.